This firm is seeking funding to take a new advanced patient monitoring device from fully functional and clinically tested prototype stage to commercial stage. The device, called a "Pulse Flowmeter, is potentially disruptive technology in the operating room, recovery room and intensive care unit, changing, in a fundamental way, doctors' approach to these acute care patients. The Pulse Flowmeter detects blood loss and heart failure very early, before there are changes in blood pressure. This can allow physicians to treat and thereby prevent their patients from going into shock. The Pulse Flowmeter does this measuring peripheral perfusion (blood flow in the arms and legs), which decreases very early as a patient is heading in the direction of developing shock. The initial target market is very large, including operating rooms, recovery rooms, surgi-centers and intensive care units. This is a platform technology with many other uses, other than those stated above. Other markets to be addressed with different versions of the device include management of chronic congestive heart failure, triaging injured soldiers on the battlefield and the management of peripheral vascular disease.
THE PULSE FLOWMETER - THE 6TH VITAL SIGN: The need and inspiration for the device originated when the inventor of the technology observed a patient die overnight from occult bleeding following minor elective surgery. This experience led directly to the invention of the Pulse Flowmeter. Every year, 40 million patients undergo surgery in the USA. Many of these will have significant bleeding. In fact 20% of all surgical patients 65 years of age and older require blood transfusions. Many of these will become hemodynamically unstable and die. It is very difficult to detect shock in its early stages because of the body's compensatory mechanisms which constrict peripheral blood flow to preserve blood flow to the heart and brain.
Every year 5 million patients in the USA are admitted to intensive care units. These patients are often hemodynamically unstable and are monitored intermittently with invasive Swan-Ganz cardiac output catheters. The Pulse Flowmeter provides similar information, but does so easily, safely, non-invasively and continuously.
MARKET FACTORS: The current medical economic climate favors innovations that result in cost-savings and improved patient outcomes.
Asking Price $5,000,000
Sales Available On Request
Profit Available On Request
You May Also Like
Distributor and Manufacturer of Electronics #469276 posted May 30, 2017
- Essex County, New Jersey, United States
Business Description: The Price Includes Approximately $ 9,800,000 In Good Saleable Inventory. This Is A Very Special Fabulous Opportunity! The company offers a wide range of high quality, electronics components and other electronics under its own brand name. The company features a comprehensive...
Computer Equipment Manufacturing Business #470509 posted Jun 16, 2017
- Toronto, Ontario, Canada
- Between $795,836 and $2,387,508 (Converted from CAD)
Long established manufacturer of industrial grade computer equipment is currently available. This would be of interest to a company already operating in the computer, communication, control, and automation industries, who is intent on growing by acquisitions. Would also be of interest to a well-qualified...
Leading Electronic Manufacturing Services Company #470300 posted Jun 13, 2017
- United States
- Available On Request
Project Circuit Theory (CT) is a leading electronic contract manufacturer and product development company which has differentiated itself through the efficient vertical integration of engineering, design, assembly, and quick turn manufacturing services. The Company is a leader in their space and...
Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness.